299 related articles for article (PubMed ID: 35427437)
1. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.
Beygi F; Mostoufi A; Mojaddami A
Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437
[TBL] [Abstract][Full Text] [Related]
2. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
3. New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti-Inflammatory and Anticancer Activity Studies.
Şenol H; Çağman Z; Gençoğlu Katmerlikaya T; Sinan Tokalı F
Chem Biodivers; 2023 Aug; 20(8):e202300773. PubMed ID: 37384873
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Cytotoxicity Evaluation and Molecular Docking of Fluorine Containing Hexahydroquinoline-3-Carbonitrile Derivatives.
Teraiya N; Karki SS; Chauhan A
Curr Drug Discov Technol; 2022; 19(1):e140122189603. PubMed ID: 33372877
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines.
Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM
Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity, apoptosis and molecular docking studies of novel phenylbutyrate derivatives as potential anticancer agents.
Mostoufi A; Baghgoli R; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():128-137. PubMed ID: 30952039
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Antiproliferative Evaluation, and Molecular Docking Study of Novel Longifolene-Derived Tetraline Fused Thiazole-Amide Derivatives.
Lan H; Zhu X; Lin G; Duan W; Cui Y; Li F; Li D
Chem Biodivers; 2023 Mar; 20(3):e202201163. PubMed ID: 36734184
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2.
Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA
Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755
[TBL] [Abstract][Full Text] [Related]
9. Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.
El-Wakil MH; El-Dershaby HA; Ghazallah RA; El-Yazbi AF; Abd El-Razik HA; Soliman FSG
Bioorg Chem; 2024 Apr; 145():107226. PubMed ID: 38377818
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
[TBL] [Abstract][Full Text] [Related]
11. New2-((2-(2,4-dinitrophenyl)hydrazineeylidene) derivatives: design, synthesis,
Sajjan VP; Anigol LB; Gurubasavaraj PM; Patil D; Patil PS; Gummagol NB; Quah CK; Wong QA; Celik I
J Biomol Struct Dyn; 2023; 41(21):11681-11699. PubMed ID: 36602778
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines.
Aydın E; Şentürk AM; Küçük HB; Güzel M
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364134
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of Novel Metacetamol Derivatives with Hydrazone Moiety as Anticancer and Antimicrobial Agents.
Şenkardeş S; Atlıhan İ; Çayır E; Mega Tiber P; Orun O; Nigiz Ş; Özkul C; Gündüz MG; Küçükgüzel ŞG
Chem Biodivers; 2023 Aug; 20(8):e202300766. PubMed ID: 37417710
[TBL] [Abstract][Full Text] [Related]
19. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
Kadhim ZY; Alqaraghuli HGJ; Abd MT
Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
